Skip to main content

Table 2 NPC incidence in China in 2013

From: Nasopharyngeal carcinoma incidence and mortality in China, 2013

Areas Sex CR (1/105) Prop (%) ASIRC (1/105) ASIRW (1/105) Cum rate (%) TASR (1/105) Rank
All Both 3.09 1.14 2.31 2.17 0.24 4.88 19
Male 4.31 1.47 3.26 3.07 0.34 7.01 14
Female 1.81 0.74 1.35 1.25 0.13 2.68 19
Urban areas Both 3.33 1.17 2.40 2.23 0.24 5.09 20
Male 4.73 1.58 3.43 3.21 0.35 7.37 14
Female 1.87 0.70 1.35 1.24 0.13 2.71 19
Rural areas Both 2.82 1.11 2.19 2.07 0.23 4.59 19
Male 3.82 1.33 3.04 2.89 0.32 6.50 12
Female 1.75 0.79 1.34 1.26 0.14 2.65 20
Eastern area Both 2.93 0.96 2.07 1.93 0.21 5.52 19
Male 4.14 1.23 2.94 2.76 0.31 8.17 14
Female 1.71 0.61 1.21 1.11 0.12 2.67 20
Middle area Both 2.89 1.15 2.25 2.15 0.24 4.77 21
Male 3.98 1.42 3.16 3.02 0.34 6.47 15
Female 1.74 0.78 1.33 1.26 0.14 2.95 20
Western area Both 4.57 1.86 3.58 3.37 0.37 6.58 18
Male 6.35 2.25 5.03 4.73 0.52 8.78 14
Female 2.72 1.32 2.12 1.99 0.21 4.31 19
  1. CR crude rate, Prop proportion, ASIRC age-standardized incidence rate by 2000 Chinese standard population, ASIRW age-standardized incidence rate by 1985 Segi’s world standard population, Cum rate cumulative rate for patients aged 0–74 years, TASR truncated age-standardized rate for patients aged 35–64 years, Rank rank of NPC incidence in all cancers’ incidences